Navigation Links
Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA
Date:10/19/2008

TR-701 Phase 1 Clinical Trial Results Disclosed

SAN DIEGO, Oct. 20 /PRNewswire/ -- Trius Therapeutics, Inc., a biopharmaceutical company developing "Best-in-Class" drugs for the treatment of serious bacterial infections, announced today that the results of multiple studies on its lead program, TR-701, and its other pipeline programs will be presented in eighteen presentations at the upcoming joint Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and Infectious Diseases Society of America (IDSA) meeting in Washington, DC. Thirteen of the presentations focus on TR-701, a second generation oxazolidinone that recently commenced Phase 2 clinical studies.

"Acceptance of these presentations by the ICAAC committee highlights the interest in and value of the TR-701 program, the Trius pipeline, and our underlying technologies," stated Jeffrey Stein, Ph.D., President and CEO of Trius Therapeutics. "We are especially pleased to provide details of our TR-701 Phase 1 clinical trial results that support the once-daily dosing and short course of therapy in our recently initiated Phase 2 study in complicated skin and skin structure infections (cSSSIs). It is also exciting to see that the results of studies by external investigators demonstrate the drug's increased potency and expanded spectrum of activity."

The presentations are as follows:

Saturday, October 25th

(Poster Summary Session, Ballroom A/B, 10:00 am - 12:00 pm)

-- Oral Presentation: Overview of TR-701 and TR-700 Posters and

Presentations

(Poster Session 23, 12:15 pm - 1:15 pm)

-- F1-334: Discovery and SAR of a Novel Series of Pyrimidine Antibacterials

Targeting Methionyl-tRNA Synthase (MetRS)

-- F1-335: In Vitro Activity of Rx100472 Against Clinically Important

Bacteria

-- F1-336: Advanced Microbiology Study of Rx100472, A Novel Methionyl-tRNA

Synthetase (MetRS) inhibi
'/>"/>

SOURCE Trius Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Trius Initiates U.S. Phase I Trial for its Oxazolidinone Antibacterial Drug, TR-701
2. PacificGMP Completes GMP Product Fill for Trius Therapeutics
3. Trius Doses First Patient in Antibacterial Phase 2 Trial
4. For Most, Good Oral Care Does More Than Antibiotics to Prevent Dental-Related Heart Problems, Reports the Harvard Heart Letter
5. ActivBiotics Proposes Development Strategy for Its Novel Rifamycin Antibiotics
6. Bad News to Bad Bugs: Northern Antibiotics Develops Novel Polymyxins With Reduced Toxicity
7. SuperGens Novel Hypomethylating Agent Highlighted at AACR Plenary Session
8. International ACTEMRA Rheumatoid Arthritis Study Highlighted in The Lancet
9. Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting
10. Blood Spot Technology at ZRT Highlighted in March Issue of Journal of Diabetes Science & Technology - A Convenient Alternative to Serum Testing for Health Screening
11. ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Aug. 29, 2014  Chuma Holdings, Inc. (OTCBB:CHUM) ... and turnkey support services for the lawfully organized ... processed and approved the Company,s name and symbol ... Corporation will be known as Chuma Holdings, Inc. ... through a merger with the Company,s wholly-owned subsidiary, ...
(Date:8/29/2014)... Aug. 29, 2014  A Boston Scientific Corporation ... on stent removability and preliminary long term stricture ... in the August issue of the peer-reviewed journal, ... is being conducted in 11 countries and ... self-expanding metal stents (FCSEMS) after extended indwell (i.e., ...
(Date:8/29/2014)... Research and Markets has announced ... Report, 2014-2017" report to their offering. ... of reimbursement for medical expenses, the Chinese orthopedic instrument ... presenting a CAGR of 19.2% during 2009-2013. Trauma products, ... of orthopedic instruments in China , ...
Breaking Medicine Technology:CannaMed Announces Name Change and Trading Symbol Change 2CannaMed Announces Name Change and Trading Symbol Change 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4China Orthopedic Instrument Industry Report, 2014-2017 2
(Date:9/2/2014)... Barcelona, Spain Tuesday 2 September 2014: Health ... heart failure guidelines, according to the results of ... Congress by Professor Aldo Maggioni. Clinical variables explained ... said: "This is a unique evaluation which combines ... countries. It provides a fuller picture of the ...
(Date:9/2/2014)... Boston, MA (PRWEB) September 02, 2014 Attorney ... Lawyers® as the 2015 "Lawyer of the Year" for ... with Lubin & Meyer PC, Boston, and has been selected ... since 2008. Only one lawyer in each practice area and ... Year,” based on particularly impressive voting averages received during the ...
(Date:9/2/2014)... BC (PRWEB) September 02, 2014 ... pioneer in Canada announced today the expansion of its ... the company’s first Chief Financial Officer. Liang joins AURO ... Web Hosting, and will work closely with the operations, ... on expanding their cloud presence as well as ensuring ...
(Date:9/1/2014)... MD (PRWEB) September 02, 2014 Securityhunter ... which necessitated conducting an extensive search for a new, larger ... expansion. “We have tripled the space of our office ... amenities of our new space, from glass topped cubicles with ... as well as a huge warehouse," says Michael S. Rogers, ...
(Date:9/1/2014)... Spine Team Texas, provider of world-class spine ... 2014’ award based on readers’ nominations of their preferred ... & Coppell, Rockwall & Rowlett, and Keller & Haslet. ... patients and the residents in the communities we serve ... of 2014’ in the areas of neurosurgery, spine surgery, ...
Breaking Medicine News(10 mins):Health News:Health structures explain nearly 20 percent of non-adherence to heart failure guidelines 2Health News:Robert Higgins Named 2015 Best Lawyers® "Lawyer of the Year" in Boston 2Health News:AURO Appoints Kevin Liang as New Chief Financial Officer for Canadian Enterprise Public Cloud 2Health News:AURO Appoints Kevin Liang as New Chief Financial Officer for Canadian Enterprise Public Cloud 3Health News:Securityhunter, Inc. Announces the Relocation of Its Corporate Headquarters in Baltimore 2Health News:Spine Team Texas chosen in LIVING Magazine’s Reader’s Choice Awards 2
... Healthcare announces the following Webcast:, What: HCA Healthcare ... Where: http://www.videonewswire.com/event.asp?id=55052 , How: ... the, address ... +1-615 344 2688, , ...
... STERIS Corporation (NYSE:, STE ) today announced ... 31, 2008. Fiscal 2009 third quarter revenues increased ... third quarter of fiscal 2008,driven by 4% growth in ... income was $28.6 million, or $0.48 per diluted share, ...
... Genetics, Inc. (NYSE Alternext US: ILI) today announced that the ... LLC (the "Exchange") that outlines the Company,s strategy to regain ... expects the Exchange to formally respond to the submitted plan ... may be able to continue its listing up to June ...
... New Couple,s Guide Provides Blueprint for Renewing RelationshipsNEW YORK, ... disappoint. But for relationships on the rocks, nothing says, ... a breakthrough guide, seasoned couples therapist and educator Marty ... with the differences that arise in any relationship. "We,ve ...
... custom fabrication offerings to include products for use in hospitals. ... work stations, surgical tools, and carts for use in the medical environment. ... ... work as a custom sheet metal fabrication house over 30 years ago. ...
... information portal with the recent addition of several new articles detailing ... drug has been linked to bone fracture, osteoporosis and heart failure ... ... 2009 -- LegalView.info, the most comprehensive legal site available on the ...
Cached Medicine News:Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 2Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 3Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 4Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 5Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 6Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 7Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 8Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 9Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 10Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 11Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 12Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 13Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 14Health News:Interleukin Genetics' Submits Plan to Regain Compliance with Continued Listing Standards 2Health News:Breakthrough Rx for Relationships Offers Hope 2Health News:Midbrook Now Offers Custom Metal Fabrication for Hospitals 2Health News:LegalView Updates Avandia Information Portal With New Articles Detailing Potentially Dangerous Side Effects 2Health News:LegalView Updates Avandia Information Portal With New Articles Detailing Potentially Dangerous Side Effects 3
Pefakit TAFI Calibrators and Controls...
Plasma Control Level 2 - 1 ml...
... 1700 was developed to address hematology ... Ease of use, low maintenance, closed-tube ... reliability are features expected in the ... made fast access to results, sophisticated ...
Inquire...
Medicine Products: